Lactobacilli supposedly have low pathogenicity; they are seldom detected in blood culture. Lactobacillus rhamnosus GG, which originates indigenously in the human intestine, became available for use as a probiotic in 1990 in Finland. We evaluated the possible effects of the increased probiotic use of L. rhamnosus GG on the occurrence of bacteremia due to lactobacilli. Lactobacilli were isolated in 0.02% of all blood cultures and 0.2% of all blood cultures with positive results in Helsinki University Central Hospital and in Finland as a whole, and no trends were seen that suggested an increase in Lactobacillus bacteremia. The average incidence was 0.3 cases/100,000 inhabitants/year in 1995-2000 in Finland. Identification to the species level was done for 66 cases of Lactobacillus bacteremia, and 48 isolates were confirmed to be Lactobacillus strains. Twenty-six of these strains were L. rhamnosus, and 11 isolates were identical to L. rhamnosus GG. The results indicate that increased probiotic use of L. rhamnosus GG has not led to an increase in Lactobacillus bacteremia.
Lactobacilli are gram-positive rods found in the normal gastrointestinal and genitourinary flora [1] . They are often regarded as contaminants with no clinical significance or as opportunistic pathogens that might cause infections in immunocompromised individuals [1] [2] [3] . In 2 surveys, lactobacilli represented only 0.1%-0.2% of all isolates found in blood cultures [4, 5] . Despite the presumed low virulence of these pathogens, cases of pneumonia, endocarditis, and local suppurative deep abscesses have been described in association with Lactobacillus infection, even in patients with normal immunity [1] . The importance of lactobacilli as path-ogens might be growing, because many case reports on Lactobacillus bacteremia in immunocompromised patients have recently been published [6] [7] [8] [9] [10] .
Live lactic acid bacteria traditionally have been widely consumed in fermented dairy food products in many countries. In addition, selected Lactobacillus strains that tolerate intestinal conditions have increasingly been used in human food because of their putative health effects. These strains, called "probiotics," are described as "live microbial feed supplements that beneficially affect the host animal by improving its microbial balance" [11] . One of the most studied probiotic strains is Lactobacillus rhamnosus GG (ATCC 53103), which was originally isolated from human intestinal flora. L. rhamnosus GG has been shown to shorten the duration and ameliorate the symptoms of infantile rotavirus diarrhea, to have some effect on preventing atopic diseases among infants, and to modulate immune responses [12] [13] [14] [15] [16] .
The safety of the widespread use of probiotics has not been thoroughly investigated, although no hazard-ous adverse events were found in a review of 143 clinical trials of probiotics [17] . Concern has been raised by reports of transfer of antibiotic resistance by a probiotic bacterium and of fungemia caused by a probiotic yeast and by a case report of an L. rhamnosus GG-like isolate in a liver abscess [18] [19] [20] .
In 1990, L. rhamnosus GG was introduced into dairy products in Finland. After a slow start, its annual consumption increased rapidly and reached 6 L/person (e.g., cfu/ 11 3 ϫ 10 person/year) in 1999. Since 1990, we have collected all Lactobacillus isolates from blood culture specimens in our survey laboratory at Helsinki University Central Hospital (HUCH; Helsinki). In addition, national surveillance of all bloodstream infections, including those caused by lactobacilli, was started in late 1994 by Finland's National Public Health Institute. We studied the possible impact of increased consumption of L. rhamnosus GG on the occurrence of bloodstream infections caused by lactobacilli, including species characterization and comparison by molecular epidemiological methods with the probiotic L. rhamnosus GG strain.
MATERIALS AND METHODS

Collection of Lactobacillus isolates, HUCH, 1990-2000.
Blood and CSF culture isolates characterized as lactobacilli were collected at our survey laboratory in HUCH during 1990-2000. For 1990-1993, blood culture isolates were retrieved from routinely stored (Ϫ70ЊC) blood culture isolates; since 1993, all Lactobacillus isolates have been stored separately when first identified. In 1997, another laboratory was merged into our survey laboratory, which expanded the catchment area and increased the number of blood culture isolates available; after that, the area covered an average population of 1.3 million, approximately one-fourth of the population of Finland.
Collection of cases of Lactobacillus bacteremia, National Infectious Disease Register (NIDR), 1995-2000. National mandatory notification of all bacterial findings in blood and CSF by all the microbiological laboratories in Finland (population at the end of the surveillance period, 5.2 million) was instituted in late 1994 as the NIDR, which is maintained by the National Public Health Institute. All clinical microbiology laboratories that had notified the NIDR of Lactobacillus findings in blood or CSF were asked to send routinely stored Lactobacillus blood culture isolates from reported cases and possibly unreported cases (those that were not reported to the NIDR but should have been) from 1995-2000 to our survey laboratory. Isolates were stored at Ϫ70ЊC until analysis was done.
Characterization of Lactobacillus strains. Characterization of the isolates to the species level was done at Valio R&D (Helsinki). The isolates were grown anaerobically at 37ЊC on de Man-Rogosa-Sharpe (MRS) agar (LabM, International Diagnostics Group) or Trypcase Soy agar (BioMérieux) supplemented with 5% horse blood. Preliminary characterization of the Lactobacillus isolates was performed according to their carbohydrate fermentation profile, using API 50 CH strips and APILAB Plus software (version 4.0; BioMérieux).
The identification was confirmed by species-specific PCR. L. rhamnosus-specific PCR was performed as described elsewhere [21] . When necessary, some Lactobacillus isolates and all potentially non-Lactobacillus isolates that did not grow on MRS agar were identified by sequencing part of the 16S rDNA [22] . All L. rhamnosus strains were compared with L. rhamnosus GG by PFGE, as described elsewhere [23] . Four restriction enzymes, NotI, SfiI, AscI, and FseI, were used separately to cut the genomic DNA of the strains. The genomic fragments were separated by agarose gel electrophoresis, using L. rhamnosus GG as a control in every gel. Electrophoresis was carried out on a CHEF DR II apparatus (Bio-Rad) in 1% PFGE Certified agarose (Bio-Rad), using 0.5ϫ TBE buffer (10ϫ TBE buffer is 89 mM Tris, 89 mM boric acid, and 25 mM EDTA [pH 8.0]). The running parameters were as follows: for AscI and FseI, pulse, 1-15 s; current, 7 V/cm; temperature, 12ЊC; time, 25 h; for NotI, 1-8 s, 6 V/cm, 14ЊC, and 27 h; and for SfiI, 1-15 s, 5 V/cm, 14ЊC, and 22 h. A 120Њ angle was used in all runs. The agarose gel was stained with ethidium bromide (0.5 mg/mL) and visualized under UV light. The PFGE patterns of the strains were compared visually.
Definitions. Lactobacillus isolates found in blood or CSF samples from a particular patient up to 3 months after the first positive isolate was detected were handled as if they were from a single case of infection. Isolates for which PFGE patterns were identical to that of L. rhamnosus GG with all 4 restriction enzymes were regarded as L. rhamnosus GG strains. Only the first blood isolate from each case was used for typing. All postmortem Lactobacillus blood isolates originating from fetus mortus samples ( ) were excluded. n p 9 Statistical analysis.
For annual incidence, the annual number of cases of Lactobacillus infection was compared with the annually registered Finnish population (according to official statistics from Statistics Finland). A linear trend test using Poisson regression was used to evaluate possible annual trends in the relative proportion of lactobacilli among all positive blood culture findings and all blood cultures [24] . This test was also used to evaluate possible trends in the annual number of positive blood cultures in relation to all blood cultures. The analyses were done with Egret for Windows (version 2.03; Cytel Software).
RESULTS
Lactobacillus bacteremia in HUCH, 1990-2000. Altogether, 43 blood culture isolates were originally reported as lactobacilli during the 11-year study period in our surveillance laboratory Figure 1 . Annual no. of cases in which blood culture isolates were reported to be lactobacilli by Helsinki University Central Hospital, 1990-2000, and the annual no. of cases in which the isolate was confirmed to be Lactobacillus rhamnosus or L. rhamnosus GG. The annual consumption in Finland of probiotic Lactobacillus GG products in food is also shown.
(15% of the 78 reported cases) were identified when a request for stored Lactobacillus isolates was sent. Of these 90 cases, 28 had been diagnosed at HUCH.
The annual number of positive blood cultures had a clear rising trend during this 6-year period (table 2). The annual proportion of reported lactobacilli among all positive blood cultures was, on average, 0.2%, and did not change during the observation period ( ). The annual incidence of Lac-P p .7100 tobacillus bacteremia in Finnish population was, on average, 0.29 cases/100,000 inhabitants/year.
Lactobacillus species. Overall, 66 isolates were available for species-level identification. Of these, 48 were shown to be Lactobacillus isolates, and 7 different species were observed (table 3). L. rhamnosus was the most common species, constituting 54% of all Lactobacillus species. Lactobacillus fermentum contributed 19% and Lactobacillus casei 15% of the isolates. Lactobacillus gasseri and Lactobacillus jensenii were found in р2 cases each. In 35 cases, 11 addition bacterial species (other than Lactobacillus) was found, and in 28 cases, lactobacilli were found on 11 occasion in blood cultures for a single patient.
Of the 66 isolates that were analyzed for species identification, 27% (18) proved to be other microorganisms; among them, 4 were Actinomyces species and 4 were Clostridium species, 3 were Bifidobacterium species, 1 was Weissella confusa, and 1 was a Carnobacterium species. Of 26 L. rhamnosus strains, 11 L. rhamnosus GG isolates were detected that were not distinguishable by PFGE from the probiotic L. rhamnosus GG strain. The annually reported and analyzed L. rhamnosus and L. rhamnosus GG isolates for HUCH and for Finland are shown, in relation to the amounts of probiotic L. rhamnosus GG consumed in Finland, in figures 1 and 2, respectively. The annual consumption of L. rhamnosus GG probiotics increased rapidly after 1995 in Finland, reached an average of 3 L/person/year in 1996, and continued to increase, to 6 L/person/year (i.e., cfu/person/year) (data from Valio). 
DISCUSSION
We used data from a large university hospital laboratory and from a mandatory national notification system for all findings of bacteria in blood to investigate whether there was an increase in bacteremia caused by Lactobacillus species in Finland during the extensive increase in the probiotic use of L. rhamnosus GG in food. No trends were observed that suggested an increase in the incidence of Lactobacillus bacteremia or in the proportion of Lactobacillus bacteremia among all cases of bacteremia. The relative proportion of lactobacilli among all isolates from blood cultures was, on average, 0.2% for the HUCH and 0.24% for Finland, which is in line with the proportions (0.1%-0.2%) that have been published elsewhere [4, 5] . In addition, in our study, the population-based incidence of Lactobacillus bacteremia could be estimated nationally and was found to be, on average, 0.29 cases/100,000 inhabitants/year. Only 61% of all the isolates originally reported by the clinical microbiology laboratories as lactobacilli were available for analysis. Approximately three-fourths of these were confirmed to be lactobacilli, which indicates that the actual occurrence of Lactobacillus bacteremia, taking into account the 15% of cases found through a separate request for stored strains, is probably lower than the incidence calculated on the basis of notifications to the national surveillance program.
In the present study, L. rhamnosus was the Lactobacillus species most commonly found in blood cultures. Eleven L. rhamnosus GG cases were found, without any temporally increasing trend that would suggest an association with the increase in the probiotic use. L. rhamnosus GG is acid and bile stable, and it attaches to and temporarily and effectively colonizes the human intestine [25] . These characteristics not only could be important to the indigenous nature and clinical efficacy of L. rhamnosus as a probiotic but also could increase the potential tendency of this species to cause infections. In 2 surveys, which included 43 and 45 Lactobacillus bacteremia cases, lactobacilli were primarily associated with an underlying disease or with immunosuppression [2, 3] . Thus, an increase in the number of immunosuppressed patients might also increase the impact of lactobacilli in clinical infections. Therefore, it would be essential, in the future, to analyze the actual relationship of different Lactobacillus findings to patient outcomes. In conclusion, the occurrence of Lactobacillus in blood culture, especially L. rhamnosus and L. rhamnosus GG, was evaluated in Finland, and no increase related to the increasing probiotic use of L. rhamnosus GG could be observed.
